MaYinglong Pharmaceutical Group Co. Ltd. | Ownership
Companies that own MaYinglong Pharmaceutical Group Co. Ltd.
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
11,606,607
2.7%
8,606,593
0.68%
09/30/2017
China Investment Corp. (Investment Management)
9,154,400
2.13%
0
0.06%
09/30/2017
Zhonghai Trust Co., Ltd.
4,565,992
1.06%
4,565,992
2.34%
09/30/2017
Huarong International Trust Co., Ltd.
4,162,653
0.97%
4,162,653
3.63%
09/30/2017
Harvest Fund Management Co., Ltd.
3,606,543
0.84%
-175,921
0.06%
09/30/2017
HuaAn Fund Management Co., Ltd.
3,593,740
0.84%
2,193,740
0.11%
12/31/2017
Lion Fund Management Co., Ltd.
1,790,700
0.42%
-868,318
0.2%
12/31/2017
China Southern Asset Management Co., Ltd.
1,676,682
0.39%
-51,800
0.03%
12/31/2017
China Asset Management Co., Ltd.
1,525,183
0.35%
-450,310
0.02%
12/31/2017
China Life AMP Asset Management Co., Ltd.
876,390
0.2%
-171,400
0.14%
12/31/2017
| Address |
No. 100 Zhoujiawan
Wuhan Hubei 430064
China
|
|
Employees
|
- |
| Website |
- |
| Updated |
07/08/2019 |
| Mayinglong Pharmaceutical Group Co., Ltd. engages in the manufacture of pharmaceutical products. It involves in the following business activities through its subsidiaries: operation of anorectal hospitals and clinics; and retail and wholesale of medicines. Its products include hemorrhoids cream, treatment for skin disease, and cough suppressants. |
